Global Thrombectomy Devices Market to reach USD 2,806.85 million by 2032 at a CAGR of 6.83% by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The increasing demand for thrombectomy devices is being propelled by several key factors contributing to robust market growth. The global rise in neurological and cardiovascular conditions such as acute ischemic stroke, pulmonary embolism, and deep vein thrombosis creates a critical need for timely and effective interventions. There is also a growing preference among patients and healthcare providers for minimally invasive treatment options. Additionally, ongoing innovations and new product launches by leading industry players, who are investing in advanced technologies and next-generation devices, are further driving market expansion by improving procedural efficiency and clinical outcomes.

DelveInsight's "Thrombectomy Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Thrombectomy Devices companies actively working in the market.

To know more about why North America is leading the market growth in the Thrombectomy Devices market, get a snapshot of the report Thrombectomy Devices Market Trends
https://www.delveinsight.com/sample-request/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Thrombectomy Devices Overview
Thrombectomy devices are medical tools used to remove blood clots from blood vessels, typically in cases of acute ischemic stroke, deep vein thrombosis (DVT), or peripheral artery disease. These devices help restore normal blood flow by mechanically extracting or breaking down the clot. They can include aspiration catheters, stent retrievers, and mechanical clot removal systems. Thrombectomy procedures are minimally invasive and are often performed in emergency settings to prevent tissue damage, reduce disability, and improve patient outcomes.

DelveInsight Analysis: The thrombectomy devices market size was worth approximately USD 1,656.88 million in 2024 and is projected to expand at a CAGR of 6.83% from 2025 to 2032, ultimately reaching around USD 2,806.85 million by 2032.

Thrombectomy Devices Market Insights
Geographically, North America is anticipated to lead the thrombectomy devices market in 2024, supported by several key factors. The region's prominence is driven by the high incidence of neurovascular, peripheral, and coronary vascular diseases, a rapidly expanding elderly population, and ongoing innovations and product launches from major medical device companies. Coupled with advanced healthcare infrastructure, favorable reimbursement policies, and growing awareness of minimally invasive procedures, these factors are expected to maintain North America's dominant position in the global market.

To read more about the latest highlights related to Thrombectomy Devices, get a snapshot of the key highlights entailed in the Thrombectomy Devices Insights
https://www.delveinsight.com/report-store/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Thrombectomy Devices Market Report
• In September 2025, Imperative Care received FDA 510(k) clearance for its Symphony® Thrombectomy System to treat pulmonary embolism (PE), expanding its use from venous thrombosis to cover the full spectrum of venous thromboembolism (VTE) patient care.
• In July 2025, Imperative Care received FDA 510(k) clearance for its Zoom 7X Catheter, a new tool for aspiration thrombectomy in ischemic stroke. As part of the Zoom Stroke System, the catheter features CenTRXTM Technology with a 96-degree pre-shaped tip designed to center in vessels and improve clot removal by optimizing aspiration in challenging anatomy.
• In February 2025, Stryker completed the acquisition of Inari Medical, Inc., significantly strengthening its position in the thrombectomy market. Inari's product portfolio, including the FlowTriever® System for pulmonary embolism and the ClotTriever® System for peripheral vessel thrombectomy, is highly complementary to Stryker's existing Neurovascular business.
• In February 2025, the TendviaTM Pulmonary Artery Thrombectomy System from Shanghai Tendfo Medical Device Co., Ltd. received approval from the China National Medical Products Administration (NMPA). The device is indicated for transcatheter thrombectomy in patients with acute high-risk or intermediate-risk pulmonary embolism, offering a minimally invasive treatment option for these critical conditions.
• In September 2024, Argon Medical Devices announced the launch of the CLEANER VacTM Thrombectomy System, specifically designed for the removal of blood clots from the peripheral venous vasculature. This disposable, large-bore aspiration system was engineered to quickly and effectively remove thrombus (blood clots) from vessels with restricted blood flow.
• Thus, owing to such developments in the market, rapid growth will be observed in the Thrombectomy Devices market during the forecast period

Key Players in the Thrombectomy Devices Market
Some of the key market players operating in the Thrombectomy Devices market include- Stryker, Abbott Laboratories, Boston Scientific Corporation, Argon Medical Devices, Contego Medical, Inc., Mermaid Medical, Surmodics, Inc., Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., Edwards Lifesciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroPort Scientific Corporation, Thrombolex, phenox GmbH, Acandis GmbH, Innova Vascular, Vesalio Inc., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., and others.

Which MedTech key players in the Thrombectomy Devices market are set to emerge as the trendsetter explore @ Key Thrombectomy Devices Companies
https://www.delveinsight.com/sample-request/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Thrombectomy Devices Market Landscape
In addition, several companies are actively investing in R&D to expand their thrombectomy device portfolios. For example, in May 2023, Akura Medical, part of the Shifamed portfolio, began its first-in-human clinical trial of the Akura mechanical thrombectomy device. This low-profile platform is designed to access and efficiently remove large, mixed-clot formations while simplifying procedural decision-making. Similarly, in April 2025, Surmodics launched the PounceTM XL Thrombectomy System, a next-generation device aimed at the rapid, non-surgical removal of acute or chronic clots from the iliac and femoral arteries, eliminating reliance on thrombolytic drugs. These innovations cater to the growing need for safer and more efficient clot removal solutions, particularly for patients ineligible for thrombolytic therapy.
Collectively, these developments are expected to drive growth in this market segment, contributing to the overall expansion of the global thrombectomy devices market.

Scope of the Thrombectomy Devices Market Report
• Coverage: Global
• Study Period: 2022-2032
• Thrombectomy Devices Market Segmentation By Product: Mechanical Thrombectomy Devices, Aspiration Thrombectomy Devices, Ultrasonic Thrombectomy Devices, and Others
• Thrombectomy Devices Market Segmentation By Application: Peripheral Vascular Thrombectomy, Coronary Vascular Thrombectomy, and Neurovascular Thrombectomy
• Thrombectomy Devices Market Segmentation By End-User: Hospitals & Clinics, Ambulatory Surgical Centers, and Others
• Thrombectomy Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Thrombectomy Devices Companies: Stryker, Abbott Laboratories, Boston Scientific Corporation, Argon Medical Devices, Contego Medical, Inc., Mermaid Medical, Surmodics, Inc., Penumbra, Inc., Medtronic, Johnson & Johnson Services, Inc., Edwards Lifesciences Corporation, Terumo Corporation, Koninklijke Philips N.V., MicroPort Scientific Corporation, Thrombolex, phenox GmbH, Acandis GmbH, Innova Vascular, Vesalio Inc., ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Thrombectomy Devices market will grow by 2032? Click to get a snapshot of the Thrombectomy Devices Market Analysis
https://www.delveinsight.com/sample-request/thrombectomy-devices-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.